Patents by Inventor Peter G. Krammer

Peter G. Krammer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
    Patent number: 9850308
    Abstract: The present invention relates to methods for treating an individual with high grade glioblastoma multiforme by preventing or disrupting the binding of CD95 to its ligand, CD95L, in vivo, whereupon that neutralization of CD95 activity reduces undesirable glial cell migration and invasion into body tissue.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: December 26, 2017
    Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS, UNIVERSITAETSKLINIKUM HEIDELBERG
    Inventors: Ana Martin-Villalba, Susanne Kleber, Benedikt Wiestler, Peter G. Krammer, Christel Herold-Mende, Ignacio Sancho-Martinez
  • NEUTRALIZATION OF CD95 ACTIVITY BLOCKS INVASION OF GLIOBLASTOMA CELLS IN VIVO
    Publication number: 20160115236
    Abstract: The present invention relates to methods for treating an individual with high grade glioblastoma multiforme by preventing or disrupting the binding of CD95 to its ligand, CD95L, in vivo, whereupon that neutralization of CD95 activity reduces undesirable glial cell migration and invasion into body tissue.
    Type: Application
    Filed: April 30, 2015
    Publication date: April 28, 2016
    Applicants: Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts, Universitaetsklinikum Heidelberg
    Inventors: Ana MARTIN-VILLALBA, Susanne KLEBER, Benedikt WIESTLER, Peter G. KRAMMER, Christel HEROLD-MENDE, Ignacio SANCHO-MARTINEZ
  • Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
    Patent number: 9309320
    Abstract: The present invention relates to methods for treating an individual with high grade glioblastoma multiforme by preventing or disrupting the binding of CD95 to its ligand, CD95L, in vivo, whereupon that neutralization of CD95 activity reduces undesirable glial cell migration and invasion into body tissue.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: April 12, 2016
    Assignees: Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, Universitaetsklinikum Heidelberg
    Inventors: Ana Martin-Villalba, Susanne Kleber, Benedikt Wiestler, Peter G. Krammer, Christel Herold-Mende, Ignacio Sancho-Martinez
  • Neutralization of CD95 Activity Blocks Invasion of glioblastoma Cells In Vivo
    Publication number: 20100322922
    Abstract: The present invention relates to methods for treating an individual with high grade glioblastoma multiforme by preventing or disrupting the binding of CD95 to its ligand, CD95L, in vivo, whereupon that neutralization of CD95 activity reduces undesirable glial cell migration and invasion into body tissue.
    Type: Application
    Filed: December 28, 2007
    Publication date: December 23, 2010
    Applicants: Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts, Universitaetsklinikum Heidelberg
    Inventors: Ana Martin-Villalba, Susanne Kleber, Benedikt Wiestler, Peter G. Krammer, Christel Herold-Mende, Ignacio Sancho-Martinez